Hybridize Therapeutics

Hybridize's mission is to help patients overcome untreated kidney diseases. We do this by developing RNA-based therapies.

Currently, we are nearing Phase 1 clinical trials (together with our partner AiCuris Anti-Infectives) for our therapy against BK-virus.